by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

that while the latest data is encouraging, new data also shows that Americans may need a booster shot against COVID in the future. Pfizer Chair/CEO Albert Bourla said in remarks on Wednesday, "There will be a need for a booster somewhere between eight and twelve months." COVID Caused US Mortality Rate To Sur

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U

ur Sahin, chief executive of the German medical start-up BioNTech, had been anxiously EFTA00162637 awaiting. `Are you sitting down?' Pfizer chief Albert Bourla asked him. The news that followed was better than Sahin had hoped: Preliminary analysis from Phase 3 trials of his company's coronavirus vaccine sh

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U